La cadena de opciones muestra datos clave de las opciones de acciones de TPI Composites a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para TPI Composites..

TPI Composites (NASDAQ:TPIC) Bolsa, Cadena de Opciones

TPI Composites

TPI Composites Inc is engaged in manufacturing composite wind blades. The company operates in wind energy and transportation industries where it manufactures structures for a bus, rail, theme parks, and trucks. Geographically the segments are divided into the U.S, Asia, Mexico, EMEA and India where the Mexico segment derives a majority of revenue.

TPI Composites Inc

WIIM

CLFD

Clearfield shares are trading lower after the company reported Q3 financial results and issued Q4 GAAP EPS guidance below estimates.

Inspire Medical Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INSP#NYSE">INSP</a>) iStocks currently in Phase 10 of its 18-phase cycle under the Adhishthana framework. Unfortunately for investors, the stock has broken below a key structural formation, the Cakra, which suggests a prolonged period of underperformance and potential bearishness. Here&#8217;s a closer look.
<h3 class="wp-block-heading">The Cakra Breakdown and Its Implications</h3>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="1200" height="472" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/08/07134537/INSP-Stock-Adhishthana-Cakra-Breakdown-.png" alt="Fig.1 Inspire Medical Stock Cakra Breakdown (Source: Adhishthana.com)" class="wp-image-17098" style="width:625px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/08/07134537/INSP-Stock-Adhishthana-Cakra-Breakdown-.png 1200w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/08/07134537/INSP-Stock-Adhishthana-Cakra-Breakdown--300x118.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/08/07134537/INSP-Stock-Adhishthana-Cakra-Breakdown--1024x403.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/08/07134537/INSP-Stock-Adhishthana-Cakra-Breakdown--768x302.png 768w" sizes="(max-width: 1200px) 100vw, 1200px" /><figcaption class="wp-element-caption">Fig.1 Inspire Medical Stock Cakra Breakdown (Source: Adhishthana.com)</figcaption></figure>
According to the Adhishthana Principles, stocks generally form a channel-like structure known as the Cakra between Phases 4 and 8. A breakout to the upside in Phase 9 typically triggers a strong rally and the beginning of a bullish long-term trend.
However, in the case of Inspire Medical, the stock broke below the Cakra, a significant bearish signal. This type of move is referred to as the "Move of Pralayā" in the Adhishthana framework, often followed by severe selling pressure and long stretches of stagnation.
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">"When the underlying breaks the Cākra on the flip side, it typically draws consolidation up to the Guna triads. The movement after the break is typically highly significant, and the selling momentum is extremely strong. Such a move shall be called the Move of Pralayā." — Adhishthana: The Principles That Govern Wealth, Time &amp; Tragedy
</blockquote>
Since this breakdown, Inspire Medical has already declined by roughly 50%, validating the pattern. Notably, early signs of weakness began surfacing in May 2025, despite continued optimism from large institutions at the time. Adhishthana signals, however, had already turned negative.&nbsp;
<h3 class="wp-block-heading">What's Next for Inspire Medical?&nbsp;</h3>
Based on the framework, Inspire Medical is unlikely to show meaningful recovery until the Guna Triads begin forming, expected to start around May 2028. That means investors could face an extended period of underperformance or continued downside pressure for nearly three more years.
Compounding the technical weakness, recent allegations regarding federal securities law violations add another layer of risk to the stock's outlook.
<h3 class="wp-block-heading">Investor Outlook</h3>
Given the clear breakdown of the Cakra and the long wait before any structural recovery is expected, investors should avoid the stock for now. The recent developments only reinforce the early bearish signals flagged by the Adhishthana Principles as far back as May 2025, well ahead of conventional market indicators.
For now, Inspire Medical remains on the avoid list until it forms a more constructive setup as it approaches its Guna Triads phase.
Benzinga Disclaimer: This article is from an unpaid external contributor. It does not represent Benzinga&#8217;s reporting and has not been edited for content or accuracy.

Equities

Technicals

Opinion

Signals

Trading Ideas

INSP

Inspire Medical Stock Strays Off Course Amid Structural Setback

Live On CNBC, Stephanie Link Announces Bought More GAP

MDU Resources Group shares are trading lower after the company reported mixed Q2 financial results and narrowed its FY25 GAAP EPS guidance with its midpoint below estimates.

Live On CNBC, Josh Brown Hosts Segment Titled "Best Stock Spotlight: TJX Companies"

<a href="https://www.theinformation.com/briefings/openai-pays-bonuses-ranging-millions-dollars-1-000-researchers-engineers" title="https://www.theinformation.com/briefings/openai-pays-bonuses-ranging-millions-dollars-1-000-researchers-engineers">https://www.theinformation.com/briefings/openai-pays-bonuses-ranging-millions-dollars-1-000-researchers-engineers</a>

News

MSFT

'OpenAI Pays Bonuses Ranging Up To Millions of Dollars to 1,000 Researchers, Engineers' - The Information

NUVL

Nuvalent shares are trading lower after the company reported worse-than-expected Q2 financial results.

Rumors

Watching Symbotic; Traders Circulate Popular Newsletter Mentions Stock As A Buy

CPRX

Catalyst Pharmaceuticals shares are trading lower. The company reported Q2 financial results.

Arch Capital Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACGL#NASDAQ">ACGL</a>) has outperformed the market over the past 20 years by 6.75% on an annualized basis producing an average annual return of 15.31%. Currently, Arch Capital Group has a market capitalization of $32.89 billion. 
Buying $100 In ACGL: If an investor had bought $100 of ACGL stock 20 years ago, it would be worth $1,728.14 today based on a price of $88.14 for ACGL at the time of writing.
<h3>Arch Capital Group's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1754584228_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACGL

$100 Invested In Arch Capital Group 20 Years Ago Would Be Worth This Much Today

IPOs

Firefly Aerospace IPO Price Indicating $73/Share; IPO Priced At $45/Share On 19.296M Shares

<figure class="wp-block-image size-large"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2025/08/2025-08-07_08h45_43.png" alt="" /></figure>
To gain an edge, this is what you need to know today.
<h4 class="wp-block-heading">Paper Tiger Tariffs</h4>
Please click here for an enlarged chart of Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>).
Note the following:
<ul class="wp-block-list">
<li>This article is about the big picture, not an individual stock.&nbsp; The chart of AAPL stock is being used to illustrate the point.</li>
<li>The chart shows the run up in AAPL stock yesterday on the news of Apple investing an additional $100B in domestic manufacturing, bringing the total commitment to $600B.</li>
<li>The chart shows the move up yesterday was on heavier volume, indicating conviction.</li>
<li>The chart shows the additional jump up in the after market when President Trump indicated an exemption for Apple from the semiconductor tariffs.</li>
<li>The chart shows AAPL stock has crossed into zone 1 (resistance).</li>
<li>RSI on the chart shows that AAPL stock is not overbought despite the up moves.</li>
<li>Prior to yesterday, there were three concerns about Apple: 
<ul class="wp-block-list">
<li>Apple needing to pay 100% semiconductor tariffs.</li>
<li>Apple needing to pay additional 50% tariffs on iPhones as most iPhones coming to the U.S. are manufactured in India.</li>
<li>Declining iPhone sales in China.</li>
</ul>
</li>
<li>President Trump has imposed 100% tariffs on semiconductors.  However, the tariffs are a paper tiger.  President Trump said, "But the good news for companies like Apple is if you&#8217;re building in the United States or have committed to build, without question, committed to build in the United States, there will be no charge."  Apple, NVIDIA Corp (NVDA), Advanced Micro Devices Inc (AMD), and Micron Technology Inc (MU) are among the stocks that are benefiting.</li>
<li>Intel Corp (INTC) was expected to benefit, but INTC stock is falling on President Trump's demand that Intel's CEO resigns.  The reason is that in the past, Intel's CEO made investments in China. As full disclosure, a signal was given this morning for Intel (INTC) in our ZYX Buy.</li>
<li>Yesterday, we shared with readers:</li>
</ul>
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">In a potential long term strategic blunder, President Trump appears to be pushing India away from the U.S. and close to China.
</blockquote>
<ul class="wp-block-list">
<li>President Trump has imposed an additional 50% tariff on India for importing oil from Russia.&nbsp; However, President Trump is not threatening similar tariffs on China even though China imports more Russian oil than India.</li>
<li>Indian Prime Minister Modi has decided to stand up to President Trump even in the face of 50% tariffs.&nbsp; India is the third country to decide to stand up to President Trump – China was the first.&nbsp; However, with China, President Trump chickened out when China turned the tables due to its stranglehold on rare earth minerals.</li>
<li>Now, India, the world's largest democracy, and Brazil, the world's fourth largest democracy, are willing to stand up to President Trump even at a significant cost.</li>
<li>Yesterday, the Treasury auction was soft.&nbsp; Here are the details: 
<ul class="wp-block-list">
<li>$42B 10-year Treasury note auction</li>
<li>High yield: 4.255% (4.304%)</li>
<li>Bid-to-cover: 2.35 (2.57)</li>
<li>Indirect bid: 64.2% (69.7%)</li>
<li>Direct bid: 19.6% (17.9%)</li>
</ul>
</li>
<li>The stock market was beginning to pullback on the soft auction when the news broke about Russia leading to renewed buying.</li>
<li>President Trump and Russian President Putin are set to meet in the coming days.&nbsp; This is bringing in buying on hope of an end to the Ukraine-Russia war.</li>
<li>Initial jobless claims came at 226K vs. 220K consensus.</li>
<li>Wall Street is drooling at the likely Trump executive order to allow private assets in 401K plans.  President Trump's order will be a big bonanza for Wall Street.  The reverse Robinhood trade continues to work well.  In our analysis, the reverse Robinhood trade is likely to pick up more steam.  In the short term, this is great for investors but not good in the long term as lower income families are increasingly paying a steeper price to make the rich richer. </li>
<li>In our analysis, a vast majority of buying that ran up the stock market yesterday and in the premarket today is coming from retail investors.  Institutional investors have turned cautious.  </li>
<li>Of special interest this morning is a big drop in Eli Lilly And Co (LLY) as disappointing obesity pill data overshadows excellent earnings.</li>
</ul>
Magnificent Seven Money Flows
In the early trade, money flows are positive in Apple (AAPL), Alphabet Inc Class C (GOOG), Meta Platforms Inc (META), Microsoft Corp (MSFT), and NVIDIA Corp (NVDA).
In the early trade, money flows are neutral in Tesla Inc (TSLA).
In the early trade, money flows are negative in Amazon.com, Inc. (AMZN).
In the early trade, money flows are positive in SPDR S&amp;P 500 ETF Trust (SPY) and Invesco QQQ Trust Series 1 (QQQ).
<h4 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h4>
Investors can gain an edge by knowing money flows in SPY and QQQ.  Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.  The most popular ETF for gold is SPDR Gold Trust (GLD).  The most popular ETF for silver is iShares Silver Trust (SLV).  The most popular ETF for oil is United States Oil ETF (USO).
<h4 class="wp-block-heading">Gold</h4>
Prudent investors should note that gold should have seen selling on the news of talks with Russia.&nbsp; Instead, gold is seeing buying.&nbsp; The buying is mostly from the momo crowd buying on momentum and being oblivious to the Russia news.&nbsp;&nbsp;
<h4 class="wp-block-heading">Bitcoin</h4>
Bitcoin is range bound.
<h4 class="wp-block-heading">What To Do Now</h4>
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h4 class="wp-block-heading">Traditional 60/40 Portfolio</h4>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
Benzinga Disclaimer: This article is from an unpaid external contributor. It does not represent Benzinga&#8217;s reporting and has not been edited for content or accuracy.

Market Summary

Markets

Tech

AAPL

Stocks Jump On 100% Semiconductor Tariffs - Apple, Nvidia, AMD, And Micron Benefit

USAR

Watching USA Rare Earth; Shares See Volume To The Upside, Traders Circulate Popular Newsletter Mentions Stock As A Buy

Figma shares are trading lower amid continued volatility following its recent IPO.

Elanco Animal Health Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELAN#NYSE">ELAN</a>) reported second-quarter 2025 results on Thursday, posting adjusted earnings per share of 26 cents, down 13% year over year.
Despite the decline, earnings exceeded both the company&#8217;s guidance range of 17 cents to 21 cents and the <a target="_blank" href="https://www.benzinga.com/quote/ELAN/earnings" rel="noreferrer noopener">consensus estimate of 20 cents</a>.
Revenue came in at $1.24 billion, surpassing the consensus estimate of $1.19 billion and exceeding management&#8217;s guidance of $1.175 billion to $1.195 billion. Sales grew 5% on a reported basis and 8% on an organic constant currency basis.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/46124598/elanco-animal-health-pipeline-earns-praise" rel="noreferrer noopener">Elanco Animal Health Gets Its Bite Back, Pipeline Efforts Earn Praise</a>
Adjusted EBITDA was $238 million in the second quarter of 2025, a 13.5% decrease.
Pet Health revenue was $643 million, an increase of 11% on a reported basis, or 10% on an organic <a target="_blank" href="https://www.benzinga.com/pressreleases/25/08/n46956336/elanco-animal-health-reports-second-quarter-2025-results" rel="noreferrer noopener">constant currency basis</a>.
The increase in pet health revenue included a 4% increase in price. New products primarily drove year-over-year volume increases of 6%.
The Advantage Family of products and Seresto contributed revenue of $147 million and $113 million, respectively.&nbsp;
Farm Animal revenue was $583 million, a decrease of 2% on a reported basis due to the sale of the aqua business, and a 6% increase on an organic constant currency basis.
Farm animal organic constant currency revenue growth included a 2% increase from price. Volumes were up 4%, driven by increased volumes in U.S. cattle, led by Experior, and increased volumes in international poultry and swine.
The business has seen&nbsp;demand recovery for international swine products, while international poultry demand remains strong.
Sales of the company&#8217;s international farm animal products benefited from accelerated customer purchases, primarily in China, in advance of expected future tariff increases, estimated to have shifted approximately $10 to $20 million of expected future purchases to the second quarter.&nbsp;
Commenting on Elanco&#8217;s earnings, William Blair said, &#8220;Elanco&#8217;s second-quarter deck has some positive key product updates for Zenrelia (label update in the U.S.), Quattro (increased sell-through in the second quarter), AdTab (60% growth), and Experior/Bovaer (continued momentum).&#8221;
Analyst Brandon Vazquez of William Blair said the solid second-quarter update reinforced the belief that Elanco is on track for a multi-year period of improving growth and margins.
<h2 class="wp-block-heading">Full-Year Guidance</h2>
&#8220;We are raising our 2025 full-year guidance for our strong second quarter execution and more favorable foreign exchange rates, more than offsetting incremental investments to fuel our innovation launches&#8230;,&#8221; said Bob VanHimbergen, Executive Vice President and CFO of Elanco Animal Health.
Elanco anticipates a tailwind to revenue of approximately $35 million from the favorable impact of foreign exchange rates compared with the May earnings call.
The company raised fiscal 2025 revenue guidance from $4.51 billion-$4.58 billion to $4.57 billion-$4.62 billion versus the consensus of $4.54 billion.
Elanco also increased its 2025 adjusted EPS from 80-86 cents to 85-91 cents versus <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">the consensus of 84 cents</a>.
Full year adjusted EBITDA includes a current estimate for net tariff impact of $10 to $14 million versus $16 to $20 million previously.
<h2 class="wp-block-heading">Third-Quarter Guidance</h2>
Elanco expects a tailwind to revenue of approximately $10 million from the favorable impact of foreign exchange rates compared to the prior year.
Excluding the impacts of foreign exchange rates and royalty revenue sold to a third party, the company expects a growth of 4%-6% in organic constant currency revenue.
Elanco forecasts third-quarter adjusted earnings of 12-16 cents per share versus the consensus of 13 cents, with sales of $1.08 billion-$1.11 billion compared to the Wall Street estimate of $1.083 billion.
The company anticipates growth to be impacted by approximately $15 million in revenue and approximately $10 million in Adjusted EBITDA of pre-tariff customer buying accelerated into the second quarter, primarily in China.
Price Action: ELAN stock surged to a 52-week high of $15.79 following the release of stronger-than-expected financial results for the second quarter of 2025. The stock is trading higher by 17.1% to $16.34 at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/earnings/25/08/46960692/eli-lillys-closely-watched-obesity-pill-orforglipron-shows-around-12-weight-loss-but-trails-novo-nordisk">Eli Lilly&#8217;s Closely Watched Obesity Pill Orforglipron Shows Around 12% Weight Loss But Trails Novo Nordisk</a></li>
</ul>
Photo by T Sxhneider via Shutterstock

Analyst Color

Earnings

Guidance

Health Care

Movers

General

ELAN

Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook

PTON

PTON stock has given up its prior gain. Peloton Interactive shares were trading higher after the company reported better-than-expected Q4 EPS and sales.

Peloton Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTON#NASDAQ">PTON</a>) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.06) by 190.91 percent. This is a 162.5 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $606.900 million which beat the analyst consensus estimate of $580.236 million by 4.60 percent. This is a 5.70 percent decrease over sales of $643.600 million the same period last year.

Earnings Beats

CORRECTION: Peloton Interactive Q4 EPS $0.05 Beats $(0.06) Estimate, Sales $606.900M Beat $580.236M Estimate

Firefly Aerospace IPO Price Indicating $72.50/Share; IPO Priced At $45/Share On 19.296M Shares

CENT

Central Garden & Pet shares are trading lower after the company reported mixed Q3 financial results.

UGI stock has given up its prior loss. UGI shares were trading lower after the company reported a Q3 sales miss.

Press Releases

TPI Composites, Inc. Announces Third Quarter 2024 Earnings Results – Operational Execution and Strategic Initiatives Drive Improved Profitability

TPI Composites, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call

TPI Composites, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Results – Expects Improved Profitability in 2025

TPI Composites Achieves Milestone: 100,000 Wind Blades Manufactured

TPI Composites Publishes Annual Sustainability Report Showcasing Its Commitments to Sustainable Operations

TPI Composites, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call

Management

Climb Global Solutions Appoints Paul Giovacchini to its Board of Directors

TPI Composites, Inc. Announces Date Change for its First Quarter 2025 Earnings Release Date and Conference Call

TPI Composites, Inc. Announces First Quarter 2025 Earnings Results – Operational Execution and Strategic Initiatives Drive Improved Financial Results; Initiation of Strategic Review

TPI Composites to Sponsor World KidWind Challenge Wind Tunnel at ACP CLEANPOWER 2025

Comments

TPI Composites

TPI Composites (TPIC) Opciones

TPI Composites (NASDAQ:TPIC) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL